A detailed history of Cowen And Company, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 2,197,385 shares of TARS stock, worth $104 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
2,197,385
Previous 2,122,530 3.53%
Holding current value
$104 Million
Previous $77.2 Million 22.59%
% of portfolio
1.53%
Previous 2.59%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$25.17 - $38.73 $1.88 Million - $2.9 Million
74,855 Added 3.53%
2,197,385 $59.7 Million
Q1 2024

May 03, 2024

BUY
$19.61 - $39.22 $4.14 Million - $8.28 Million
211,131 Added 11.05%
2,122,530 $77.2 Million
Q4 2023

Feb 12, 2024

BUY
$12.98 - $20.73 $24.8 Million - $39.6 Million
1,911,399 New
1,911,399 $38.7 Million
Q3 2023

Nov 09, 2023

SELL
$14.75 - $24.62 $2.99 Million - $4.99 Million
-202,610 Reduced 10.13%
1,796,773 $31.9 Million
Q2 2023

Aug 07, 2023

BUY
$11.57 - $19.63 $23.1 Million - $39.2 Million
1,999,383 New
1,999,383 $36.1 Million
Q3 2022

Nov 14, 2022

SELL
$14.08 - $18.5 $171,705 - $225,607
-12,195 Reduced 2.28%
522,329 $8.94 Million
Q1 2022

May 16, 2022

BUY
$14.49 - $24.28 $293,205 - $491,305
20,235 Added 3.93%
534,524 $8.99 Million
Q2 2021

Aug 13, 2021

BUY
$27.16 - $38.59 $14 Million - $19.8 Million
514,289 New
514,289 $14.9 Million

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.26B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.